Yu HA, Sima C, Feldman D, Liu LL, Vaitheesvaran B, Cross J, Rudin CM, Kris MG, Pao W, Michor F, Riely GJ.2017.Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.Annals of oncology : official journal of the European Society for Medical Oncology.28(2):278-284.Pubmed: 28073786DOI:10.1093/annonc/mdw556
Yu HA, Sima C, Feldman D, Liu LL, Vaitheesvaran B, Cross J, Rudin CM, Kris MG, Pao W, Michor F, Riely GJ.2017.Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.Annals of oncology : official journal of the European Society for Medical Oncology.28(2):278-284.Pubmed: 28073786DOI:10.1093/annonc/mdw556
Franziska Michor uses the tools of theoretical evolutionary biology, applied mathematics, statistics, and computational biology to address important questions in cancer research.
